Unbiased estimates of long-term net survival of solid cancers in France

International Journal of Cancer

Volumn 132, Issue 10, 2013, Pages 2370-2377

  Jooste, Valérie ^a,b,c   Grosclaude, Pascale ^a,d   Remontet, Laurent ^e,f,g,h   Launoy, Guy ^a,i   Baldi, Isabelle ^a,j   Molinié, Florence ^a,k   Arveux, Patrick ^a,l   Bossard, Nadine ^e,f,g,h   Bouvier, Anne Marie ^a,b,c   Colonna, Marc ^a,m  

^a Network of French Cancer Registries (FRANCIM)   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f UNIVERSITÉ DE LYON   (France)

^g UNIVERSITÉ LYON 1   (France)

^h LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

ⁱ Axe 2: 'Biology and Innovative Therapeutics for Locally Aggressive Cancers'   (France)

^j Inst de Santé Publique   (France)

^k NANTES UNIVERSITY HOSPITAL   (France)

^l CENTRE GEORGES FRANÇOIS LECLERC   (France)

^m Registre des Cancers de l'Isre   (France)

more..

Author keywords

cancer; net survival; population based study; registries; survival analysis

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; FOLLOW UP; FRANCE; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; SOLID TUMOR; SURVIVAL PREDICTION; TESTIS CANCER; THYROID CANCER;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; BIAS (EPIDEMIOLOGY); FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASMS; PROGNOSIS; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 84874943424     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27857     Document Type: Article

References (16)

1. Bossard N, Velten M, Remontet L, et al. Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer 2007; 43: 149-60.
2. Perme MP, Stare J, Esteve J,. On estimation in relative survival. Biometrics 2012; 68: 113-20.
3. Danieli C, Remontet L, Bossard N, et al. Estimating net survival: the importance of allowing for informative censoring. Stat Med 2012; 31: 775-86.
4. Corazziari I, Quinn M, Capocaccia R,. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40: 2307-16.
5. Bouvier AM, Remontet L, Hedelin G, et al. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis. Cancer 2009; 115: 4616-24.
6. Roche L, Danieli C, Belot A, et al. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods. Int J Cancer, submitted.
7. Berrino F, Richiardi L, Boffetta P, et al. Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control 2003; 14: 213-23.
8. Tryggvadottir L, Gislum M, Bray F, et al. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49: 624-31.
9. Ries L, Young J, Keel G, Eisner M, Lin Y, M-J H, editors. SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. Bethesda, MD: National Cancer Institute, SEER Program, NIH Pub. No. 07-6215; 2007.
10. Bray F, Klint A, Gislum M, et al. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006. Acta Oncol 2010; 49: 644-54.
11. Colonna M, Bossard N, Remontet L, et al. Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: a study of five common cancers. Int J Cancer 2010; 127: 924-31.
12. Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2009) (www.seer.cancer.gov/popdata), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released January 2011.
13. Jessup JM, Stewart A, Greene FL, et al. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA 2005; 294: 2703-11.
14. Bielska-Lasota M, Inghelmann R, van de Poll-Franse L, et al. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study. Gynecol Oncol 2007; 105: 609-19.
15. Klint A, Tryggvadottir L, Bray F, et al. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010; 49: 632-43.
16. Pukkala E, Malila N, Hakama M,. Socioeconomic differences in incidence of cervical cancer in Finland by cell type. Acta Oncol 2010; 49: 180-4.